Glucocorticoid-Induced Fatty Liver Disease
Leili Rahimi,1 Aman Rajpal,1,2 Faramarz Ismail-Beigi1,2 1Department of Medicine, Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, OH, USA; 2Cleveland VA Medical Center, Cleveland, OH, USACorrespondence: Faramarz Ismail-BeigiDepartment of Medicine, Case Weste...
Guardado en:
Autores principales: | Rahimi L, Rajpal A, Ismail-Beigi F |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c82fe6d3d6a24257a465929983374ba5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The interplay between abdominal aortic aneurysm, metabolic syndrome and fatty liver disease: a retrospective case-control study
por: Mahamid M, et al.
Publicado: (2019) -
Inadequate identification of fatty liver disease, obesity, and metabolic syndrome by family physicians
por: Mahamid M, et al.
Publicado: (2018) -
Effects of liraglutide on lipolysis and the AC3/PKA/HSL pathway
por: Li Z, et al.
Publicado: (2019) -
Obesity management in Prader–Willi syndrome: current perspectives
por: Crinò A, et al.
Publicado: (2018) -
Plasma concentrations of zonulin are elevated in obese men with fatty liver disease
por: Kim AS, et al.
Publicado: (2018)